FITB
58
2
CINF
53
-3
ZION
52
-3
TRV
56
-9
WM
77
-3
EA
63
-2
FTI
69
-2
GRMN
40
-5
WDC
40
2
ETR
66
-2
AVGO
27
-8
APD
42
-3
JNJ
57
3
EQT
50
-7
PBI
40
-2
KMX
53
-2
STI
20
2
CMG
43
-4
ALL
64
-12
FSLR
32
-2
FITB
58
2
CINF
53
-3
ZION
52
-3
TRV
56
-9
WM
77
-3
EA
63
-2
FTI
69
-2
GRMN
40
-5
WDC
40
2
ETR
66
-2
AVGO
27
-8
APD
42
-3
JNJ
57
3
EQT
50
-7
PBI
40
-2
KMX
53
-2
STI
20
2
CMG
43
-4
ALL
64
-12
FSLR
32
-2
Financhill
Back

Ulta Beauty 10K Form

Sell
32

ULTA
Ulta Beauty

Last Price:
$343.68
Seasonality Move:
10.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ULTA News And Ratings

See the #1 stock for the next 7 days that we like better than ULTA

ULTA Financial Statistics

Sales & Book Value

Annual Sales: $11.3B
Cash Flow: $962.6M
Price / Cash Flow: 16.91
Annual Sales: $53.66
Price / Book: 6.41

Profitability

EPS (TTM): 25.37000
Net Income (TTM): $1.2B
Gross Margin: $4.4B
Return on Equity: 51.13%
Return on Assets: 20.68%

Ulta Beauty Earnings Forecast

Key Ulta Beauty Financial Ratios

  • The Gross Profit Margin over the past 23 years for ULTA is 38.84%.
  • The Selling, General & Administrative Expenses for ULTA have been equal to 24.86% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ULTA is 10.63% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 18 years.

Ulta Beauty Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Specialty Retail
Sector: Consumer Discretionary
Current Symbol: ULTA
CUSIP: 90384S
Website: ulta.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.7
Quick Ratio: 0.52

Price-to-Earnings

Trailing P/E Ratio: 13.57
Forward P/E Ratio: 13.41

ULTA Technical Analysis vs Fundamental Analysis

Sell
32
Ulta Beauty (ULTA) is a Sell

Is Ulta Beauty a Buy or a Sell?

  • Ulta Beauty stock is rated a Sell
    The current Ulta Beauty [ULTA] share price is $343.83. The Score for ULTA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.